These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported Terminated 2005-002192-32 Phase II Randomized, Parallel-Group Trial on PTK-ZK with or without DTIC in Patients with non-resectable Metastatic Malignant Melanoma 2008-10-31 due-trials
Ongoing 2006-001791-20 A Phase II, single center open label, prospective trial to evaluate the efficacy and safety of mepolizumab for patients with refractory or relapsing Churg Strauss Syndrome not-yet-due
Exempt Terminated 2006-002675-41 A non-randomised, multi-center Phase I/II trial of safety, tolerability and efficacy of Everolimus (RAD001) in relapsed or refractory Multiple Myeloma 2010-07-01 not-yet-due
Ongoing 2006-005104-14 A pilot study to investigate the safety and efficacy of a combined treatment with Gemcitabine and Sulfasalazine in pancreatic ductal adenocarcinoma not-yet-due
Ongoing 2006-006912-31 Vereidung maschineller Beatmung bei sehr kleinen Frühgeborenen - Avoid mechanical ventilation (The AMV-Trial) not-yet-due
Not reported 2007-001558-21 Phase II Studie: Neoadjuvante Radiochemotherapie mit Capecitabin und Oxaliplatin plus Bevacizumab beim lokal fortgeschrittenen Rektumkarzinom 2012-11-20 due-trials
Not reported 2007-001918-16 Combined Treatment of Sorafenib and pegylated interferon α2b in stage IV metastatic melanoma: a prospective non-randomized, multicenter Phase II Study SoraPeg Trial 2009-11-04 due-trials
Ongoing 2007-004270-43 International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia not-yet-due
Completed, but no date Terminated 2007-004280-22 Re-irradiation combined with cetuximab for the treatment of patients with locally recurrent or with secondary squamous cell carcinoma of the head and neck bad-data
Listed as ongoing, but also has a completion date and reported results 2007-006658-24 A randomised controlled trial to compare the safety and effectiveness of doxycycline (200 mg/day) with prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid 2014-10-10 bad-data
Other 2008-001032-12 Phase 2 trial of pemetrexed (Alimta™) combined with paclitaxel in patients with recurrent/advanced follicular, papillary or anaplastic thyroid cancer 2013-05-15 not-yet-due
Not reported Terminated 2008-003833-25 Efficacy ans safety of subcutaneous Efalizumab in the treatment of patients with cutaneous lupus erythematosus: A mono-centre, open-label, prospective pilot study 2009-05-13 due-trials
Exempt 2009-014532-37 Effekte von oraler Cortisol oder Propranolol-Gabe auf die Verarbeitung alkoholbezogener Schlüsselreize, den Schlaf und das Rückfallrisiko von alkoholabhängigen Patienten (Copro-Studie). not-yet-due
Ongoing 2009-017472-25 „Duplex-kontrollierte, katheter-gestützte Schaumsklerosierung (DKKS) von Krampfadern in Kombination mit Tumeszenzlösungsapplikation (TLA)“ not-yet-due
Completed, but no date Terminated 2010-018637-21 Intravitreal Injection of Lucentis (Ranibizumab) after Pars Plana Vitrectomy and Subretinal Application of Recombinant Tissue Plasminogen Activator (rtPA) in Patients with Acute Submacular Hemorrhage ... bad-data
Other 2010-018993-20 Multicenter phase II study of panitumumab, docetaxel, 5-FU, leucovorin and oxaliplatin (P-FLOT) in patients with metastatic or locally advanced Kras wild type adenocarcinoma of the stomach or the gast... not-yet-due
Ongoing 2010-021777-37 "A prospective, non-randomized, mono-center, cohort study to evaluate the short- and long-term effects of 0.5mg intraocular Ranibizumab (Lucentis) injections on retinal function in patients with wet a... not-yet-due
Not reported 2010-021790-37 Comparison of clinical and metabolic effects of testosterone and estradiol in adult gonadectomized patients with 46,XY DSD due to complete androgen insensitivity syndrome (CAIS) 2016-08-16 due-trials
Completed, but no date Terminated 2010-023427-18 Definitive radiochemotherapy with 5-FU / cisplatin plus/minus cetuximab in unresectable locally advanced esophageal cancer: a phase II study bad-data
Not reported 2011-002202-70 A prospective, non-randomized, mono-center, cohort study to evaluate the effects of 0.5mg intraocular Ranibizumab (Lucentis) injections on retinal function in patients with diabetic macular edema (DME... 2013-07-04 due-trials
Not reported Terminated 2011-003628-11 Tapentadol PR vs Oxycodon CR A pilotstudiy for a mechanism-orientated Therapy of peripheral chronic neuropathic pain syndrom 2013-11-25 due-trials
Other 2012-000447-27 Open Label Study for the Functional Characterization of Drug Metabolism and Transport in patients before routine visceral surgery not-yet-due
Not reported 2013-001866-40 The effect of Zinc-D-gluconate on bleeding propensity of the periodontium in patients with chronic parodontitis - a randomised, placebo-controlled, double-blind interventional study 2016-06-21 due-trials
Completed, but no date 2015-002588-40 Exploratory Evaluation of Biomarkers associated with Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients bad-data
Completed, but no date 2016-000205-36 A Single-Centre, Exploratory Trial to Assess the Mechanisms of Molecular Activity, Safety and Tolerability of One Dose Level of FE 999301 by Intravenous Infusions in Patients with Active Inflammatory ... bad-data
Ongoing 2016-001935-12 AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia not-yet-due
No trial status on register 2018-001664-38 A proof of concept and assessment of maximal effect study with low dose Fenfluramine as add-on therapy in Myoclonic Astatic Epilepsy (Doose-Syndrome) bad-data
Ongoing 2018-004043-23 Cognitive function after liver transplantation comparing Tacrolimus formulations not-yet-due
Ongoing 2019-000598-22 Effects of Tralokinumab treatment of atopic dermatitis on skin barrier function (TraSki) not-yet-due